HYPD
Price
$3.68
Change
-$0.03 (-0.81%)
Updated
Jun 23, 04:07 PM (EDT)
Capitalization
56.24M
50 days until earnings call
Intraday BUY SELL Signals
INKT
Price
$12.32
Change
+$0.07 (+0.57%)
Updated
Jun 23, 03:40 PM (EDT)
Capitalization
60.81M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HYPD vs INKT

HYPD vs INKT Comparison Chart in %
View a ticker or compare two or three
VS
HYPD vs. INKT commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPD is a Hold and INKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (HYPD: $3.71 vs. INKT: $12.21)
Brand notoriety: HYPD and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HYPD: 108% vs. INKT: 51%
Market capitalization -- HYPD: $56.24M vs. INKT: $60.81M
HYPD [@Biotechnology] is valued at $56.24M. INKT’s [@Biotechnology] market capitalization is $60.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPD’s FA Score shows that 1 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • HYPD’s FA Score: 1 green, 4 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, both HYPD and INKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPD’s TA Score shows that 6 TA indicator(s) are bullish while INKT’s TA Score has 5 bullish TA indicator(s).

  • HYPD’s TA Score: 6 bullish, 4 bearish.
  • INKT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HYPD is a better buy in the short-term than INKT.

Price Growth

HYPD (@Biotechnology) experienced а +27.05% price change this week, while INKT (@Biotechnology) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was +1969.89%.

Reported Earning Dates

HYPD is expected to report earnings on Aug 12, 2026.

INKT is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($60.8M) has a higher market cap than HYPD($56.2M). INKT YTD gains are higher at: 9.464 vs. HYPD (4.213). INKT has higher annual earnings (EBITDA): -12.67M vs. HYPD (-31.79M). INKT has more cash in the bank: 9.53M vs. HYPD (7.38M). INKT has less debt than HYPD: INKT (5.73M) vs HYPD (9.07M). HYPD has higher revenues than INKT: HYPD (1.04M) vs INKT (0).
HYPDINKTHYPD / INKT
Capitalization56.2M60.8M92%
EBITDA-31.79M-12.67M251%
Gain YTD4.2139.46445%
P/E RatioN/AN/A-
Revenue1.04M0-
Total Cash7.38M9.53M77%
Total Debt9.07M5.73M158%
FUNDAMENTALS RATINGS
HYPD: Fundamental Ratings
HYPD
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HYPDINKT
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
HYPD
Daily Signal:
Gain/Loss:
INKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NREAX15.060.20
+1.37%
Neuberger Real Estate A
VCRVX16.010.08
+0.50%
NYLI CBRE Global Infrastructure Inv Cl
ASQIX21.65N/A
N/A
American Century Small Company Inv
TILHX30.48N/A
N/A
Nuveen Large Cap Growth I
EMQCX10.44N/A
N/A
Ashmore Emerging Markets Active Eq C

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with KYNB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then KYNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
+7.54%
KYNB - HYPD
48%
Loosely correlated
+1.47%
ACXP - HYPD
36%
Loosely correlated
-1.82%
INKT - HYPD
34%
Loosely correlated
+0.54%
CTXR - HYPD
33%
Poorly correlated
+6.41%
QNTM - HYPD
31%
Poorly correlated
-3.68%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been closely correlated with REVB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if INKT jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
+0.54%
REVB - INKT
66%
Closely correlated
+5.10%
RAIN - INKT
43%
Loosely correlated
-9.71%
CYPH - INKT
42%
Loosely correlated
-2.19%
PHVS - INKT
40%
Loosely correlated
+0.61%
PTHS - INKT
37%
Loosely correlated
+0.97%
More